To further support the notion that ATF3 represses SLC7A11 expression, we analyzed publicly available gene expression datasets and found that the ATF3 expression level inversely correlated with the SLC7A11 level in two cohorts of glioma patients (Fig. 6g). The gene discussed is ATF3; the disease is central nervous system cancer.